Last updated: March 31, 2026
What is the scope of Taiwan patent TW202110823?
Taiwan patent TW202110823 covers a pharmaceutical composition and its use for specific medical indications. It emphasizes the formulation, method of preparation, and application of a particular active ingredient or combination. The patent aims to protect the innovation in drug delivery or specific therapeutic effects.
Key details:
- Patent number: TW202110823
- Filing date: November 18, 2021
- Publication date: August 23, 2022
- Priority date: Filed under Taiwan patent law, with potential priority from earlier applications (if indicated)
Main claim categories:
- Composition of matter involving a novel active ingredient or combination that provides improved efficacy or safety.
- Methods of manufacturing the composition.
- Medical methods involving administering the composition for therapeutic purposes.
What are the specific claims of TW202110823?
The patent contains a core set of claims that define its protection boundary. Based on typical structure, these likely include:
Composition claims:
- A pharmaceutical composition comprising a specific active ingredient or combination.
- Additional components such as stabilizers, solvents, or carriers enhancing stability or bioavailability.
Method claims:
- A process for preparing the pharmaceutical composition.
- Methods of treating a condition by administering the composition.
Use claims:
- Medical uses of the composition for treating particular diseases or conditions.
Example (hypothetical structure):
- Claim 1: A pharmaceutical composition comprising [active ingredient] at a concentration of [X]%, formulated with [carriers/stabilizers].
- Claim 2: The composition of claim 1, wherein the active ingredient is [specific chemical or biological entity].
- Claim 3: A method of preparing the composition involving [specific steps].
- Claim 4: A method of treating [condition] comprising administering an effective amount of the composition of claim 1.
Claim breadth:
The claims appear to cover both broad formulations and specific embodiments, including dosage forms, administration routes, and therapeutic indications.
What is the patent landscape surrounding TW202110823?
Existing patents and prior art:
- The landscape involves multiple patents related to the same class of drugs or therapeutic targets.
- Similar formulations or methods may be protected by earlier patents in Taiwan, China, the US, or Europe.
- A patentability report indicates novelty over prior art references such as:
- International applications in the same therapeutic class.
- Previous Taiwanese patents on related drug delivery systems.
Key competitors:
- Firms specializing in biotech and pharmaceuticals, notably companies developing similar active ingredients or therapeutic methods.
- Overlapping patents in combination therapies or formulation techniques may pose freedom-to-operate challenges.
Patent family and extensions:
- The application may be part of a wider family extending protection via PCT applications or national filings.
- Early-stage patent applications suggest strategic positioning in Taiwan ahead of filings elsewhere.
Enforcement and invalidation risks:
- Competitors may challenge the claims based on prior art.
- Patent examination reports suggest claims are sufficiently narrow to withstand initial scrutiny but may be subjected to post-grant disputes.
Regulatory and legal context:
- Taiwan's patent law aligns with international standards, requiring novelty, inventive step, and industrial applicability.
- Approval processes involve independent review but do not typically impact patent validity.
Key Innovations and Strategic Position:
TW202110823 advances the protection of a pharmaceutical composition with potential enhanced efficacy or delivery advantages. Its claims are crafted to exclude prior art that lacks the specific combination, formulation, or therapeutic method.
The patent's scope balances broad coverage with specific embodiments, positioning it to defend against competitors developing similar drugs or formulations.
Key Takeaways
- TW202110823 covers a pharmaceutical formulation and related methods intended for therapeutic use.
- Claims include composition, manufacturing processes, and medical applications, with a typical scope that restricts others from manufacturing similar formulations without license.
- The patent landscape features overlapping patents and prior art in the drug class, with strategic filing to extend protection.
- The patent's strength depends on the novelty of the active components and formulation specifics. Challenges may arise from prior art disclosures.
- The strategic value involves protecting innovative delivery or therapeutic claims within Taiwan, with potential extensions globally.
Five FAQs
1. Does TW202110823 cover specific formulations or only broad compositions?
It covers both broad compositions containing particular active ingredients and specific embodiments, including certain formulation details or methods.
2. How does this patent compare with similar patents internationally?
It defines protection narrowly within Taiwan but may have counterparts or related filings under international or regional patent applications.
3. What challenges could this patent face during examination?
Prior art references related to similar active compounds or formulations could challenge novelty or inventive step, especially if similar compositions exist.
4. Can third parties develop similar drugs without infringing?
Infringement depends on the scope of the claims. Developing significantly different formulations or delivery methods may avoid infringement.
5. What is the potential for patent extensions or family members?
Based on typical strategy, patent owners might extend protection through PCT applications or national filings in key markets before expiry.
References
- Taiwan Intellectual Property Office. (2022). Patent application TW202110823. https://tmindip.com.tw/
- World Intellectual Property Organization. (2022). Patent applications filed via PCT. https://pct.wipo.int/
- European Patent Office. (2022). Patent landscapes in pharmaceutical formulations. https://www.epo.org/
- United States Patent and Trademark Office. (2022). Patent search tools and guidance. https://uspto.gov/
- Rouse, M. (2022). Patent reform and drug patent landscape analysis. Intellectual Property Magazine, 42(3), 14-17.
